The global human embryonic stem cell market has seen substantial growth, driven by its transformative potential in regenerative medicine, drug development, and treatment for complex conditions. With a market value of approximately USD 0.94 billion in 2023, the industry is poised to expand at a CAGR of 10.6% from 2024 to 2032, reaching an estimated […]
